Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertension

Gina Parcesepe; Richard J Allen; Beatriz Guillen-Guio; Samuel Moss; R Gisli Jenkins; Louise V Wain

doi:10.1183/23120541.00457-2023

Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertension

ERJ Open Res. 2023 Nov 13;9(6):00457-2023. doi: 10.1183/23120541.00457-2023. eCollection 2023 Nov.

Authors

Gina Parcesepe^{1

2}, Richard J Allen^{1

2}, Beatriz Guillen-Guio^{1

2}, Samuel Moss³, R Gisli Jenkins³, Louise V Wain^{1

2}

Affiliations

¹ Department of Population Health Sciences, University of Leicester, Leicester, UK.
² NIHR Leicester Biomedical Research Centre, Leicester, UK.
³ Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK.

Abstract

The discovery of shared genetic associations, with sometimes different directions of effect, has implications for drug target discovery for idiopathic pulmonary fibrosis and systemic hypertension https://bit.ly/45IqbRv.

Abstract

Grants and funding